Stocktoria
Savara Inc SVRA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2001-06-25
Savara Inc statistics & valuation
Market cap$1.2B
P / B6.0×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -46.9% | -45.0% | -30.8% | -27.3% | -24.4% |
| Return on equity | -58.5% | -55.9% | -39.0% | -35.4% | -29.8% |
| Debt / equity | 0.15× | 0.16× | 0.19× | 0.24× | 0.18× |
| Current ratio | 11.85 | 13.73 | 15.66 | 21.98 | 11.26 |
Source: SEC EDGAR filings · CIK 0001160308 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.